GlycoMimetics, Inc.

220 articles with GlycoMimetics, Inc.

• The Market Publishers, Ltd. Release: Generic Drug Companies Discussed in New Research Report Recently Published at MarketPublishers.com

  12/13/2011

• Progress of GlycoMimetics, Inc.’s Novel Compounds Highlighted at 2011 Annual Meeting of the American Society of Hematology

  12/13/2011

• GlycoMimetics, Inc. Inks Licensing Deal Worth Up to $340 Million with Pfizer Inc.

  10/11/2011

• GlycoMimetics, Inc. Announces Data Presentations on Lead Compound at American Society of Hematology Annual Meeting

  12/8/2010

• Blood Publishes Pre-Clinical Data on GlycoMimetics, Inc. Lead Compound in Sickle Cell Disease Model

  9/28/2010

• Key GlycoMimetics, Inc. Patents Issue in the U.S.

  7/14/2010

• GlycoMimetics, Inc. Initiates Phase 2 Clinical Trial of Lead Candidate GMI-1070 in Sickle Cell Patients

  6/24/2010

• GlycoMimetics, Inc. Announces Two Oral Presentations on Lead Drug Candidate GMI-1070 at American Society of Hematology Annual Meeting

  12/7/2009

• GlycoMimetics, Inc. Attracts $38 Million in Latest Venture Round

  10/21/2009

• New Drug to Treat Sickle Cell Crisis Begins Pilot Study in Patients, GlycoMimetics, Inc. Study

  9/3/2009

• GlycoMimetics, Inc. Awarded National Institutes of Health (NIH) Grant to Study Drug Candidate in Diabetes

  8/17/2009

• Nature Reviews: Drug Discovery Article Describes Design of GlycoMimetics, Inc. Compounds and Newly “Druggable” Disease Targets

  7/24/2009

• Dana-Farber Cancer Institute Presents Results of GlycoMimetics, Inc.'s Lead Drug Candidate in Models of Multiple Myeloma at American Society of Clinical Oncology Annual Meeting

  5/28/2009

• GlycoMimetics, Inc. Completes Phase 1 Clinical Studies of Lead Drug Candidate

  3/26/2009

• GlycoMimetics, Inc. to Present New Results of Lead Candidate in Additional Animal Models of Sickle Cell Disease at American Society of Hematology Annual Meeting

  12/8/2008

• GlycoMimetics, Inc. Commences Phase 1 Clinical Trial of Lead Drug Candidate

  9/5/2008

• GlycoMimetics, Inc. to Present Results of Lead Drug Candidate in Animal Models of Sickle Cell Disease at American Society of Hematology Annual Meeting

  12/10/2007

• GlycoMimetics, Inc. Highlights Advances in Lead Drug Candidate for Sickle Cell Patients at International Glycobiology Conference

  7/20/2007

• GlycoMimetics, Inc. Secures $15.4-Million In Series B

  6/23/2006

• Tech Council of Maryland Release: Area Life Science Companies Chosen To Make Presentations For Venture Funding At 2005 Mid-Atlantic Bio

  10/12/2005